Loading…
Selective Up-Regulation of Phosphodiesterase-4 Cyclic Adenosine 3′,5′-Monophosphate (cAMP)-Specific Phosphodiesterase Variants by Elevated cAMP Content in Human Myometrial Cells in Culture
In human myometrium, the modulation of intracellular cAMP content resulting from agonist-mediated stimulation of the receptor-adenylyl cyclase complex is largely influenced by the rate of cAMP hydrolysis by phosphodiesterase (PDE) isoenzymes. We have previously shown that the PDE4 family contributes...
Saved in:
Published in: | Endocrinology (Philadelphia) 1999-07, Vol.140 (7), p.3228-3237 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c510t-f156824c96cd2ec0e81963938e0e85202cbcbad72b8d59b6e7f07fd7fabfbfab3 |
---|---|
cites | cdi_FETCH-LOGICAL-c510t-f156824c96cd2ec0e81963938e0e85202cbcbad72b8d59b6e7f07fd7fabfbfab3 |
container_end_page | 3237 |
container_issue | 7 |
container_start_page | 3228 |
container_title | Endocrinology (Philadelphia) |
container_volume | 140 |
creator | Méhats, C Tanguy, G Dallot, E Robert, B Rebourcet, R Ferré, F Leroy, M. J |
description | In human myometrium, the modulation of intracellular cAMP content
resulting from agonist-mediated stimulation of the receptor-adenylyl
cyclase complex is largely influenced by the rate of cAMP hydrolysis by
phosphodiesterase (PDE) isoenzymes. We have previously shown that the
PDE4 family contributes to the predominant cAMP-hydrolyzing activity in
human myometrium and that elevation of the PDE4B2 messenger RNA steady
state level occurs in pregnant myometrial tissue.
In the present study, we used a model of human myometrial cells in
culture to determine whether an elevated cAMP concentration could
influence PDE expression. As in myometrial tissue, high levels of PDE4
activity were detected in these smooth muscle cells. Long term
treatment with 8-bromo-cAMP or forskolin resulted in a selective
induction of PDE4B and of PDE4D short form messenger RNA variants.
Concurrently, an increased immunoreactive signal for the PDE4B- and
PDE4D-related isoenzymes was detected. This induction was consistent
with an observed significant up-regulation of PDE4 activity.
Accordingly, our results demonstrate that in human cultured myometrial
cells, cAMP-elevating agents manipulate PDE4 activity through selective
induction of synthesis of PDE4B and PDE4D short forms. Such a mechanism
might have physiological importance during pregnancy by dampening
hormonal stimulation and could thereby be involved in tolerance to the
tocolytic effect of β-adrenoceptor agonists. |
doi_str_mv | 10.1210/endo.140.7.6847 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69852444</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1210/endo.140.7.6847</oup_id><sourcerecordid>3130518757</sourcerecordid><originalsourceid>FETCH-LOGICAL-c510t-f156824c96cd2ec0e81963938e0e85202cbcbad72b8d59b6e7f07fd7fabfbfab3</originalsourceid><addsrcrecordid>eNqNkc9qFTEUxoMo9vbq2p0EBKni3CbzLzPLy1BboReLtW5DJnPGpmSSMckU7s5n8gl8Fp-kGaegKIKbkxzO7_s4yYfQM0o2NKXkGExnNzQnG7Ypq5w9QCta50XCKCMP0YoQmiUsTdkBOvT-JrZ5nmeP0QElWVXktF6h75egQQZ1C_hqTD7A50mLoKzBtscX19aP17ZT4AM44SHJcbOXWkm87cBYrwzg7MfXb2-KWJKdNXb8KREB8JHc7i5eJZcjSNVHxV9m-JNwSpjgcbvHJxpuo6rDswo31gQwASuDz6ZBGLzb2wFCxDVuQGs_T5pJh8nBE_SoF9rD0_tzja7ennxszpLz96fvmu15IgtKQtLToqzSXNal7FKQBCpal1mdVRCvRUpS2cpWdCxtq66o2xJYT1jfsV60fRtLtkYvF9_R2S9TfAQflJdxGWHATp6XdbSZv3eNXvwB3tjJmbgbz2hGClqxgkXqeKGks9476Pno1CDcnlPC52j5HC2P0XLG52ij4vm979QO0P3GL1lG4PUC2Gn8D7dygeeBdDHJ0YH3v3b9l_AOirbExQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3130518757</pqid></control><display><type>article</type><title>Selective Up-Regulation of Phosphodiesterase-4 Cyclic Adenosine 3′,5′-Monophosphate (cAMP)-Specific Phosphodiesterase Variants by Elevated cAMP Content in Human Myometrial Cells in Culture</title><source>Oxford Journals Online</source><creator>Méhats, C ; Tanguy, G ; Dallot, E ; Robert, B ; Rebourcet, R ; Ferré, F ; Leroy, M. J</creator><creatorcontrib>Méhats, C ; Tanguy, G ; Dallot, E ; Robert, B ; Rebourcet, R ; Ferré, F ; Leroy, M. J</creatorcontrib><description>In human myometrium, the modulation of intracellular cAMP content
resulting from agonist-mediated stimulation of the receptor-adenylyl
cyclase complex is largely influenced by the rate of cAMP hydrolysis by
phosphodiesterase (PDE) isoenzymes. We have previously shown that the
PDE4 family contributes to the predominant cAMP-hydrolyzing activity in
human myometrium and that elevation of the PDE4B2 messenger RNA steady
state level occurs in pregnant myometrial tissue.
In the present study, we used a model of human myometrial cells in
culture to determine whether an elevated cAMP concentration could
influence PDE expression. As in myometrial tissue, high levels of PDE4
activity were detected in these smooth muscle cells. Long term
treatment with 8-bromo-cAMP or forskolin resulted in a selective
induction of PDE4B and of PDE4D short form messenger RNA variants.
Concurrently, an increased immunoreactive signal for the PDE4B- and
PDE4D-related isoenzymes was detected. This induction was consistent
with an observed significant up-regulation of PDE4 activity.
Accordingly, our results demonstrate that in human cultured myometrial
cells, cAMP-elevating agents manipulate PDE4 activity through selective
induction of synthesis of PDE4B and PDE4D short forms. Such a mechanism
might have physiological importance during pregnancy by dampening
hormonal stimulation and could thereby be involved in tolerance to the
tocolytic effect of β-adrenoceptor agonists.</description><identifier>ISSN: 0013-7227</identifier><identifier>EISSN: 1945-7170</identifier><identifier>DOI: 10.1210/endo.140.7.6847</identifier><identifier>PMID: 10385419</identifier><language>eng</language><publisher>United States: Endocrine Society</publisher><subject>3',5'-Cyclic-AMP Phosphodiesterases - genetics ; 3',5'-Cyclic-AMP Phosphodiesterases - metabolism ; 8-Bromo Cyclic Adenosine Monophosphate - pharmacology ; Adenosine ; Adenylate cyclase ; Adrenergic receptors ; Agonists ; Cell culture ; Cells, Cultured ; Colforsin - pharmacology ; Cyclic AMP ; Cyclic AMP - metabolism ; Cyclic Nucleotide Phosphodiesterases, Type 3 ; Cyclic Nucleotide Phosphodiesterases, Type 4 ; Cycloheximide - pharmacology ; Dactinomycin - pharmacology ; Enzyme Induction - physiology ; Female ; Forskolin ; Gene expression ; Homeostasis - physiology ; Humans ; Immunoblotting ; Isoenzymes ; Isoenzymes - metabolism ; Myometrium ; Myometrium - cytology ; Myometrium - drug effects ; Myometrium - metabolism ; Nucleic Acid Synthesis Inhibitors - pharmacology ; Osmolar Concentration ; Phosphodiesterase ; Physiological effects ; Protein Synthesis Inhibitors - pharmacology ; RNA, Messenger - metabolism ; Smooth muscle ; Stimulation ; Time Factors ; Tissue culture ; Up-regulation</subject><ispartof>Endocrinology (Philadelphia), 1999-07, Vol.140 (7), p.3228-3237</ispartof><rights>Copyright © 1999 by The Endocrine Society 1999</rights><rights>Copyright © 1999 by The Endocrine Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c510t-f156824c96cd2ec0e81963938e0e85202cbcbad72b8d59b6e7f07fd7fabfbfab3</citedby><cites>FETCH-LOGICAL-c510t-f156824c96cd2ec0e81963938e0e85202cbcbad72b8d59b6e7f07fd7fabfbfab3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10385419$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Méhats, C</creatorcontrib><creatorcontrib>Tanguy, G</creatorcontrib><creatorcontrib>Dallot, E</creatorcontrib><creatorcontrib>Robert, B</creatorcontrib><creatorcontrib>Rebourcet, R</creatorcontrib><creatorcontrib>Ferré, F</creatorcontrib><creatorcontrib>Leroy, M. J</creatorcontrib><title>Selective Up-Regulation of Phosphodiesterase-4 Cyclic Adenosine 3′,5′-Monophosphate (cAMP)-Specific Phosphodiesterase Variants by Elevated cAMP Content in Human Myometrial Cells in Culture</title><title>Endocrinology (Philadelphia)</title><addtitle>Endocrinology</addtitle><description>In human myometrium, the modulation of intracellular cAMP content
resulting from agonist-mediated stimulation of the receptor-adenylyl
cyclase complex is largely influenced by the rate of cAMP hydrolysis by
phosphodiesterase (PDE) isoenzymes. We have previously shown that the
PDE4 family contributes to the predominant cAMP-hydrolyzing activity in
human myometrium and that elevation of the PDE4B2 messenger RNA steady
state level occurs in pregnant myometrial tissue.
In the present study, we used a model of human myometrial cells in
culture to determine whether an elevated cAMP concentration could
influence PDE expression. As in myometrial tissue, high levels of PDE4
activity were detected in these smooth muscle cells. Long term
treatment with 8-bromo-cAMP or forskolin resulted in a selective
induction of PDE4B and of PDE4D short form messenger RNA variants.
Concurrently, an increased immunoreactive signal for the PDE4B- and
PDE4D-related isoenzymes was detected. This induction was consistent
with an observed significant up-regulation of PDE4 activity.
Accordingly, our results demonstrate that in human cultured myometrial
cells, cAMP-elevating agents manipulate PDE4 activity through selective
induction of synthesis of PDE4B and PDE4D short forms. Such a mechanism
might have physiological importance during pregnancy by dampening
hormonal stimulation and could thereby be involved in tolerance to the
tocolytic effect of β-adrenoceptor agonists.</description><subject>3',5'-Cyclic-AMP Phosphodiesterases - genetics</subject><subject>3',5'-Cyclic-AMP Phosphodiesterases - metabolism</subject><subject>8-Bromo Cyclic Adenosine Monophosphate - pharmacology</subject><subject>Adenosine</subject><subject>Adenylate cyclase</subject><subject>Adrenergic receptors</subject><subject>Agonists</subject><subject>Cell culture</subject><subject>Cells, Cultured</subject><subject>Colforsin - pharmacology</subject><subject>Cyclic AMP</subject><subject>Cyclic AMP - metabolism</subject><subject>Cyclic Nucleotide Phosphodiesterases, Type 3</subject><subject>Cyclic Nucleotide Phosphodiesterases, Type 4</subject><subject>Cycloheximide - pharmacology</subject><subject>Dactinomycin - pharmacology</subject><subject>Enzyme Induction - physiology</subject><subject>Female</subject><subject>Forskolin</subject><subject>Gene expression</subject><subject>Homeostasis - physiology</subject><subject>Humans</subject><subject>Immunoblotting</subject><subject>Isoenzymes</subject><subject>Isoenzymes - metabolism</subject><subject>Myometrium</subject><subject>Myometrium - cytology</subject><subject>Myometrium - drug effects</subject><subject>Myometrium - metabolism</subject><subject>Nucleic Acid Synthesis Inhibitors - pharmacology</subject><subject>Osmolar Concentration</subject><subject>Phosphodiesterase</subject><subject>Physiological effects</subject><subject>Protein Synthesis Inhibitors - pharmacology</subject><subject>RNA, Messenger - metabolism</subject><subject>Smooth muscle</subject><subject>Stimulation</subject><subject>Time Factors</subject><subject>Tissue culture</subject><subject>Up-regulation</subject><issn>0013-7227</issn><issn>1945-7170</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqNkc9qFTEUxoMo9vbq2p0EBKni3CbzLzPLy1BboReLtW5DJnPGpmSSMckU7s5n8gl8Fp-kGaegKIKbkxzO7_s4yYfQM0o2NKXkGExnNzQnG7Ypq5w9QCta50XCKCMP0YoQmiUsTdkBOvT-JrZ5nmeP0QElWVXktF6h75egQQZ1C_hqTD7A50mLoKzBtscX19aP17ZT4AM44SHJcbOXWkm87cBYrwzg7MfXb2-KWJKdNXb8KREB8JHc7i5eJZcjSNVHxV9m-JNwSpjgcbvHJxpuo6rDswo31gQwASuDz6ZBGLzb2wFCxDVuQGs_T5pJh8nBE_SoF9rD0_tzja7ennxszpLz96fvmu15IgtKQtLToqzSXNal7FKQBCpal1mdVRCvRUpS2cpWdCxtq66o2xJYT1jfsV60fRtLtkYvF9_R2S9TfAQflJdxGWHATp6XdbSZv3eNXvwB3tjJmbgbz2hGClqxgkXqeKGks9476Pno1CDcnlPC52j5HC2P0XLG52ij4vm979QO0P3GL1lG4PUC2Gn8D7dygeeBdDHJ0YH3v3b9l_AOirbExQ</recordid><startdate>19990701</startdate><enddate>19990701</enddate><creator>Méhats, C</creator><creator>Tanguy, G</creator><creator>Dallot, E</creator><creator>Robert, B</creator><creator>Rebourcet, R</creator><creator>Ferré, F</creator><creator>Leroy, M. J</creator><general>Endocrine Society</general><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19990701</creationdate><title>Selective Up-Regulation of Phosphodiesterase-4 Cyclic Adenosine 3′,5′-Monophosphate (cAMP)-Specific Phosphodiesterase Variants by Elevated cAMP Content in Human Myometrial Cells in Culture</title><author>Méhats, C ; Tanguy, G ; Dallot, E ; Robert, B ; Rebourcet, R ; Ferré, F ; Leroy, M. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c510t-f156824c96cd2ec0e81963938e0e85202cbcbad72b8d59b6e7f07fd7fabfbfab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>3',5'-Cyclic-AMP Phosphodiesterases - genetics</topic><topic>3',5'-Cyclic-AMP Phosphodiesterases - metabolism</topic><topic>8-Bromo Cyclic Adenosine Monophosphate - pharmacology</topic><topic>Adenosine</topic><topic>Adenylate cyclase</topic><topic>Adrenergic receptors</topic><topic>Agonists</topic><topic>Cell culture</topic><topic>Cells, Cultured</topic><topic>Colforsin - pharmacology</topic><topic>Cyclic AMP</topic><topic>Cyclic AMP - metabolism</topic><topic>Cyclic Nucleotide Phosphodiesterases, Type 3</topic><topic>Cyclic Nucleotide Phosphodiesterases, Type 4</topic><topic>Cycloheximide - pharmacology</topic><topic>Dactinomycin - pharmacology</topic><topic>Enzyme Induction - physiology</topic><topic>Female</topic><topic>Forskolin</topic><topic>Gene expression</topic><topic>Homeostasis - physiology</topic><topic>Humans</topic><topic>Immunoblotting</topic><topic>Isoenzymes</topic><topic>Isoenzymes - metabolism</topic><topic>Myometrium</topic><topic>Myometrium - cytology</topic><topic>Myometrium - drug effects</topic><topic>Myometrium - metabolism</topic><topic>Nucleic Acid Synthesis Inhibitors - pharmacology</topic><topic>Osmolar Concentration</topic><topic>Phosphodiesterase</topic><topic>Physiological effects</topic><topic>Protein Synthesis Inhibitors - pharmacology</topic><topic>RNA, Messenger - metabolism</topic><topic>Smooth muscle</topic><topic>Stimulation</topic><topic>Time Factors</topic><topic>Tissue culture</topic><topic>Up-regulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Méhats, C</creatorcontrib><creatorcontrib>Tanguy, G</creatorcontrib><creatorcontrib>Dallot, E</creatorcontrib><creatorcontrib>Robert, B</creatorcontrib><creatorcontrib>Rebourcet, R</creatorcontrib><creatorcontrib>Ferré, F</creatorcontrib><creatorcontrib>Leroy, M. J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Endocrinology (Philadelphia)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Méhats, C</au><au>Tanguy, G</au><au>Dallot, E</au><au>Robert, B</au><au>Rebourcet, R</au><au>Ferré, F</au><au>Leroy, M. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Selective Up-Regulation of Phosphodiesterase-4 Cyclic Adenosine 3′,5′-Monophosphate (cAMP)-Specific Phosphodiesterase Variants by Elevated cAMP Content in Human Myometrial Cells in Culture</atitle><jtitle>Endocrinology (Philadelphia)</jtitle><addtitle>Endocrinology</addtitle><date>1999-07-01</date><risdate>1999</risdate><volume>140</volume><issue>7</issue><spage>3228</spage><epage>3237</epage><pages>3228-3237</pages><issn>0013-7227</issn><eissn>1945-7170</eissn><abstract>In human myometrium, the modulation of intracellular cAMP content
resulting from agonist-mediated stimulation of the receptor-adenylyl
cyclase complex is largely influenced by the rate of cAMP hydrolysis by
phosphodiesterase (PDE) isoenzymes. We have previously shown that the
PDE4 family contributes to the predominant cAMP-hydrolyzing activity in
human myometrium and that elevation of the PDE4B2 messenger RNA steady
state level occurs in pregnant myometrial tissue.
In the present study, we used a model of human myometrial cells in
culture to determine whether an elevated cAMP concentration could
influence PDE expression. As in myometrial tissue, high levels of PDE4
activity were detected in these smooth muscle cells. Long term
treatment with 8-bromo-cAMP or forskolin resulted in a selective
induction of PDE4B and of PDE4D short form messenger RNA variants.
Concurrently, an increased immunoreactive signal for the PDE4B- and
PDE4D-related isoenzymes was detected. This induction was consistent
with an observed significant up-regulation of PDE4 activity.
Accordingly, our results demonstrate that in human cultured myometrial
cells, cAMP-elevating agents manipulate PDE4 activity through selective
induction of synthesis of PDE4B and PDE4D short forms. Such a mechanism
might have physiological importance during pregnancy by dampening
hormonal stimulation and could thereby be involved in tolerance to the
tocolytic effect of β-adrenoceptor agonists.</abstract><cop>United States</cop><pub>Endocrine Society</pub><pmid>10385419</pmid><doi>10.1210/endo.140.7.6847</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0013-7227 |
ispartof | Endocrinology (Philadelphia), 1999-07, Vol.140 (7), p.3228-3237 |
issn | 0013-7227 1945-7170 |
language | eng |
recordid | cdi_proquest_miscellaneous_69852444 |
source | Oxford Journals Online |
subjects | 3',5'-Cyclic-AMP Phosphodiesterases - genetics 3',5'-Cyclic-AMP Phosphodiesterases - metabolism 8-Bromo Cyclic Adenosine Monophosphate - pharmacology Adenosine Adenylate cyclase Adrenergic receptors Agonists Cell culture Cells, Cultured Colforsin - pharmacology Cyclic AMP Cyclic AMP - metabolism Cyclic Nucleotide Phosphodiesterases, Type 3 Cyclic Nucleotide Phosphodiesterases, Type 4 Cycloheximide - pharmacology Dactinomycin - pharmacology Enzyme Induction - physiology Female Forskolin Gene expression Homeostasis - physiology Humans Immunoblotting Isoenzymes Isoenzymes - metabolism Myometrium Myometrium - cytology Myometrium - drug effects Myometrium - metabolism Nucleic Acid Synthesis Inhibitors - pharmacology Osmolar Concentration Phosphodiesterase Physiological effects Protein Synthesis Inhibitors - pharmacology RNA, Messenger - metabolism Smooth muscle Stimulation Time Factors Tissue culture Up-regulation |
title | Selective Up-Regulation of Phosphodiesterase-4 Cyclic Adenosine 3′,5′-Monophosphate (cAMP)-Specific Phosphodiesterase Variants by Elevated cAMP Content in Human Myometrial Cells in Culture |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T09%3A49%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Selective%20Up-Regulation%20of%20Phosphodiesterase-4%20Cyclic%20Adenosine%203%E2%80%B2,5%E2%80%B2-Monophosphate%20(cAMP)-Specific%20Phosphodiesterase%20Variants%20by%20Elevated%20cAMP%20Content%20in%20Human%20Myometrial%20Cells%20in%20Culture&rft.jtitle=Endocrinology%20(Philadelphia)&rft.au=Me%CC%81hats,%20C&rft.date=1999-07-01&rft.volume=140&rft.issue=7&rft.spage=3228&rft.epage=3237&rft.pages=3228-3237&rft.issn=0013-7227&rft.eissn=1945-7170&rft_id=info:doi/10.1210/endo.140.7.6847&rft_dat=%3Cproquest_cross%3E3130518757%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c510t-f156824c96cd2ec0e81963938e0e85202cbcbad72b8d59b6e7f07fd7fabfbfab3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3130518757&rft_id=info:pmid/10385419&rft_oup_id=10.1210/endo.140.7.6847&rfr_iscdi=true |